Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
Faron doses first patient in BLAZE trial testing bexmarilimab with nivolumab against immunotherapy-resistant cancers
Dealroom.co1 min read
Faron doses first patient in BLAZE trial testing bexmarilimab with nivolumab against immunotherapy-resistant cancers Dealroom
Read the full article at Dealroom.coRelated coverage
AI & Society
How to build a cancer vaccine, and whether they will work this time
LessWrong · Jun 8, 2026
Links #5: 2026/07
LessWrong · Jul 31, 2026
Bill Gates Will NOT And CANNOT Inject Us With A Microchip In A Vaccine - Fails Basic Fact Check
science20.com · Aug 20, 2026
Machine Learning
Apply for Anthropic’s AI for Science rare disease research grants
Anthropic · Jul 20, 2026